摘要
目的探讨青柏溃结汤灌肠对溃疡性结肠炎(UC)大肠湿热证患者的黏膜愈合及血清炎性因子的影响,探讨其治疗UC的机制。方法将2014年1月至2015年12月陕西中医药大学第二附属医院消化内科收治的活动期轻中度UC患者120例随机分为对照组和观察组,每组60例。2组患者均给予美沙拉嗪缓释颗粒1 g,每日4次,口服,疗程4周;观察组患者在口服美沙拉嗪缓释颗粒的同时给予青柏溃结汤保留灌肠,每日1次,连续4周。治疗前及治疗4周后,观察2组患者内镜下结肠黏膜愈合情况,并抽取清晨空腹肘静脉血,采用酶联免疫吸附试验测血清肿瘤坏死因子-α(TNF-α)、白细胞介素-6(IL-6)水平,采用散射光比浊法测血清C反应蛋白(CRP)水平。治疗前后对所有患者采用Rachmilewitz评分标准进行内镜下结肠病变评分。治疗2、4周后,参照中华医学会消化病学分会炎症性肠病协作组的标准评价临床疗效。结果 2组患者治疗前结肠黏膜评分比较差异无统计学意义(P>0.05);治疗4周后,观察组患者结肠黏膜评分与对照组比较显著降低(P<0.05);观察组患者内镜下缓解53例(88.33%),对照组患者内镜下缓解43例(71.67%),观察组患者内镜下缓解率显著高于对照组(χ~2=5.208,P<0.05)。治疗前,2组患者血清IL-6、TNF-α及CRP水平比较差异均无统计学意义(P>0.05);治疗4周后,2组患者血清IL-6、TNF-α及CRP水平均较治疗前显著降低(P<0.05),且观察组患者血清IL-6、TNF-α及CRP水平均显著低于对照组(P<0.05)。治疗2周后,对照组与观察组患者的总有效率分别为40.00%、88.34%;治疗4周后,对照组与观察组患者的总有效率分别为86.67%、96.67%;观察组患者治疗2、4周后的总有效率均显著高于对照组(χ~2=30.480、3.927,P<0.05)。结论青柏溃结汤灌肠联合美沙拉嗪缓释颗粒口服治疗能降低UC患者的血清相关炎性细胞因子水平,抑制UC患者的炎症反应,促进结肠黏膜愈合,缓解�
Objective To investigate the effect and the mechanism of Qingbaikuijietang enema on colonic mucosa healing and serum inflammatory factors in patients with ulcerative colitis（UC） and large intestine damp-heat syndrome. Methods A total of 120 patients with mild and moderate UC were selected from January 2014 to December 2015 in the Second Affiliated Hospital of Shaanxi University of Traditional Chinese Medicine. The patients were randomly divided into control group and observation group,with 60 cases in each group. The patients in the two groups were treated with mesalazine sustained release granules 1 g by oral,4 times a day for 4 weeks. Based on this,the patients in the observation group were given retention enema with Qingbaikuijietang,once a day for 4 weeks. The score of colonic mucosa healing under endoscopy were evaluated before and at 4 weeks after treatment. The levels of serum tumor necrosis factor-α（TNF-α） and interleukin-6（IL-6） were determined by enzyme linked immunosorbent assay,and the level of C-reactive protein（CRP） was determined by scattering turbidimetry before and after 4 weeks of treatment. The endoscopic colonic lesions of all patients were scored by Rachmilewitz scoring standard before and after treatment. The clinical effect was evaluated by the standard set by the Cooperative Group of Inflammatory Bowel Disease in Digestive Diseases Branch of Chinese Medical Association after 2 and 4 weeks of treatment. Results There was no significant difference in the score of colon mucosa healing between the two groups before treatment（P〈0. 05）. The score of colonic lesions in the observation group was significantly lower than that in the control group after 4 weeks of treatment（P〈0. 05）. A total of 53 cases（88. 33%） in the observation group and 43 cases（71. 67%） in the control group were endoscopically remission,the remission rate in the observation group was significantly higher than that in the control group（χ~2= 5. 208,P〈0. 05）. There was no significant di
作者
张伟
杨银利
张林
林俊超
郝蕾
吴洁琼
相祎
ZHANG Wei;YANG Yin-li;ZHANG Lin;LIN Jun-chao;HA Lei;WE Jie-qiong;XIANG Yi(Department of Digestive System iseases, the Second Affiliated Hospital of Shaanxi University of Traditional Chinese Medi- cine ,Xianyang 712000 , Shaanxi Provinee , China;the Second Clinical Medical College of, Shaanxi University of Traditional Chinese Medicine, Xianyang 712000, Shaanxi Prcminee, China)
出处
《新乡医学院学报》
CAS
2018年第6期474-477,共4页
Journal of Xinxiang Medical University
基金
陕西省教育厅专项科研项目(编号:17JK0196)
陕西省中医药管理局基础平台科研项目(编号:JCPT047)
陕西中医药大学第二附属医院青年基金项目(编号:2016QN02)
